0001104659-24-024574.txt : 20240215 0001104659-24-024574.hdr.sgml : 20240215 20240215170904 ACCESSION NUMBER: 0001104659-24-024574 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240213 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 24644760 BUSINESS ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 8-K 1 tm246435d1_8k.htm FORM 8-K
false 0001558569 0001558569 2024-02-13 2024-02-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): February 13, 2024

 

iSpecimen Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40501   27-0480143
(State or other jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

450 Bedford Street
Lexington, MA 02420

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (781) 301-6700

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which
registered
Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

On February 13, 2024, iSpecimen Inc. (the “Company”) entered into certain warrant repurchase and termination agreements (the “Repurchase Agreement”) with certain holders (each, the “Warrant Holder”) of warrants (the “Warrants”) with an issuance date of December 1, 2021 at an exercise price of $13.00 per share for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), in connection with an aggregate of up to 1,312,500 shares of Common Stock exercisable under the Warrants. The Warrants were issued to the Warrant Holders in a private placement offering of the Company’s securities closed on December 2, 2021, and the resale of the shares of Common Stock issuable upon exercise of the Warrants were registered under an effective Registration Statement on Form S-1, as amended (File Number: 333-261640), filed by the Company.

 

Pursuant to the Repurchase Agreement, the Company agreed to repurchase from the Warrant Holders, who agreed to sell and transfer to the Company, the Warrants for an amount in cash equal to $0.04 multiplied by the total maximum number of shares of Common Stock issuable to the Warrant Holders upon the full exercise of the Warrants. In addition, upon full payment for the Warrants sold under the Repurchase Agreement, the Warrants and any warrants agreements or any other agreements, documents or instruments relating to the Warrants (including that certain Securities Purchase Agreements, dated November 28, 2021, by and between the Company and the Warrant Holders, that certain Registration Rights Agreements, dated November 28, 2021 by and between the Company and the Warrant Holders) (collectively, the “Warrant Documentation”) would terminate, and all past, current and future obligations of the Company relating to the Warrants and Warrant Documentation would be released, discharged and of no further force or effect.

 

A copy of the form of the Repurchase Agreement is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 1.02 Termination of a Material Definitive Agreement

 

The information contained above in Item 1.01 related to the termination of the Warrants and Warrant Documentation is hereby incorporated by reference into this Item 1.02.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits.

 

Exhibit No. Description
10.1 Form of Warrant Repurchase and Termination Agreements between the Company and certain Warrant Holders
104 Cover Page Interactive Data File

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: February 15, 2024

 

  iSPECIMEN INC.
     
  By: /s/ Tracy Curley
    Name: Tracy Curley
    Title: Chief Executive Officer

 

 

 

EX-10.1 2 tm246435d1_ex10-1.htm EXHIBIT 10.1

 

Exhibit 10.1

 

WARRANT REPURCHASE AND TERMINATION AGREEMENT

 

This WARRANT REPURCHASE AND TERMINATION AGREEMENT (this “Agreement”), dated and effective as of                 , 2024 (the “Effective Date”), is entered into by and between                    (“Warrant Holder”), and iSpecimen Inc., a Delaware corporation (the “Company”). The Warrant Holder and the Company are sometimes each referred to herein as a “Party” and collectively as the “Parties”.

 

WHEREAS, the Warrant Holder holds common stock purchase warrants with an issuance date of December 1, 2021 (the “Warrants”), which were issued to the Warrant Holder in connection with a private placement offering of the Company’s securities closed on December 2, 2021 (the “Offering”; the other investors participating in the Offering are referred to herein as the “Other Holders”, and the common stock purchase warrants issued to such Other Holders, the “Other Warrants”), and are exercisable for up to an aggregate of                shares (the “Warrant Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at an exercise price of $13.00 per share of Common Stock; and

 

WHEREAS, the Parties have agreed to the repurchase and termination of the Warrants upon the terms and subject to the conditions set forth herein.

 

NOW, THEREFORE, in consideration of the covenants, terms, conditions, restrictions, acknowledgments and stipulations set forth herein, and for other good and valuable consideration, the receipt and sufficient of which are hereby acknowledged, the Parties agree as follows:

 

1.              Repurchase and Payment; Termination of Warrants and Warrant Documentation.

 

1.1               Upon the execution of this Agreement by the Parties, the Company shall repurchase from the Warrant Holder, and the Warrant Holder shall sell and transfer to the Company, the Warrants for an amount in cash equal to four cents ($0.04) multiplied by the total maximum number of Warrant Shares issuable to the Warrant Holder upon the Warrant Holder’s full exercise of the Warrants. Payment shall be made by wire transfer of immediately available funds no later than two (2) business days following the date hereof to an account designated in writing by the Warrant Holder.

 

1.2               Upon full payment as set forth in Section 1.1 above, (a) the Warrant Holder shall return and tender to the Company all of the Warrants held by it and the Company shall remove such Warrants from the Company’s warrant register, and (b) the Warrants and any warrants agreements or any other agreements, documents or instruments relating to the Warrants (including that certain Securities Purchase Agreement, dated November 28, 2021, by and between the Company and each of the purchasers identified on the signature pages thereto, that certain Registration Rights Agreement, dated November 28, 2021 by and between the Company and each of the investors set forth therein) (collectively, the “Warrant Documentation”) shall terminate, and, in consideration of such payment, all past, current and future obligations of the Company under or relating to the Warrants and any Warrant Documentation shall be released, discharged and of no further force or effect.

 

2.              Representations and Warranties of the Warrant Holder. The Warrant Holder hereby represents and warrants to the Company that:

 

2.1               Organization; Power; Authority. The Warrant Holder is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization and has the full right, power and authority to enter into this Agreement and to sell, transfer, convey, assign and deliver the Warrants to the Company and complete the transactions contemplated by this Agreement. This Agreement has been duly authorized, executed and delivered by the Warrant Holder and constitutes the valid and binding obligation of the Warrant Holder, enforceable in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium or other similar laws relating to or affecting the rights of creditors generally and by equitable principles.

 

 

 

 

2.2               No Conflicts. The execution, delivery and performance of this Agreement, the sale, transfer, conveyance, assignment and delivery of the Warrants, and compliance with the provisions hereof by the Warrant Holder, do not and will not, with or without the passage of time or the giving of notice or both, (a) violate any provision of law, statute, ordinance, rule or regulation or any ruling, writ, injunction, order, judgment or decree of any court, administrative agency or other governmental body or authority, or (b) result in any breach of any of the terms, conditions or provisions of, or constitute a default (or give rise to any right of termination, cancellation or acceleration) under, or result in the creation of any lien, security interest, charge or encumbrance upon any of the properties or assets of the Warrant Holder, under the organizational documents of the Warrant Holder, or any note, indenture, mortgage or lease, or any other material contract or other instrument, document or agreement to which the Warrant Holder is a party or by which it or any of its property is bound or affected. The Warrant Holder is not a party to, subject to or bound by any agreement or any judgment, order, writ, prohibition, injunction or decree of any court or other governmental body or authority which would prevent the execution or delivery of this Agreement by the Warrant Holder or the sale, transfer, conveyance, assignment and delivery of the Warrants to the Company pursuant to the terms hereof.

 

2.3               Consents. All consents, approvals or authorizations of, or registrations, filings or declarations with, any governmental body or authority or any other person or entity required in connection with the execution, delivery and performance by the Warrant Holder of this Agreement or the transactions contemplated hereby have been obtained by the Warrant Holder and are in full force and effect.

 

2.4               Good Title; No Liens. The Warrant Holder is the sole owner of, and has good, valid and marketable title to, the Warrants, free and clear of any and all covenants, conditions, restrictions, voting trust arrangements, shareholder agreements, liens, pledges, charges, security interests, encumbrances, options and adverse claims or rights whatsoever (collectively, “Liens”). The Warrant Holder does not hold any additional common stock purchase warrants of the Company other than the Warrants. Upon consummation of the repurchase contemplated hereby, the Company will acquire from the Warrant Holder good, valid and marketable title to the Warrants, free and clear of all Liens.

 

2.5               Investment Representations. The Warrant Holder acknowledges that the Company may possess such material, non-public information about the Company that has not been disclosed to the Warrant Holder. The Warrant Holder acknowledges and agrees that except for the representations and warranties set forth in Section 3, the Company makes no representations or warranties with respect to itself, its business, results of operations, future prospects, financial condition or otherwise and the Warrant Holder is not relying upon any statement of fact or omission to state any fact by the Company. The Warrant Holder has received and carefully reviewed the Company’ s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, all subsequent public filings of the Company with the Securities and Exchange Commission, other publicly available information regarding the Company, and such other information that it and its advisers deem necessary to make its decision to enter into this Agreement. The Warrant Holder has evaluated the merits and risks of the transaction contemplated by this Agreement based exclusively on its own independent review and consultations with such investment, legal, tax, accounting and other advisers as it deemed necessary. The Warrant Holder has made its own decision concerning the transactions contemplated by this Agreement without reliance on any representation or warranty of, or advice from, the Company. Neither the Company nor any of its directors, officers, stockholders, employees and agents (i) has been requested to or has provided the Warrant Holder with any information or advice with respect to the transaction contemplated hereby nor is such information or advice necessary or desired, or (ii) has made or makes any representation as to the Company, the Warrants or the Warrant Documentation except as expressly set forth in Section 3. The Warrant Holder acknowledges and understands that the Company possesses material nonpublic information regarding itself not known to the Warrant Holder that may affect the value of the Warrants, (the “Information”), and that the Company is not disclosing the Information to the Warrant Holder. The Warrant Holder understands, based on its experience, the disadvantage to which it is subject due to the disparity of information between the Warrant Holder and the Company. Notwithstanding such disparity, the Warrant Holder has deemed it appropriate to enter into this Agreement and to consummate the transactions contemplated hereby. The Warrant Holder agrees that none of the Company or its affiliates, principals, stockholders, directors, officers, employees and agents shall have any liability to the Warrant Holder or its affiliates, principals, stockholders, partners, employees, agents, grantors or beneficiaries, whatsoever due to or in connection with the Company’s non-disclosure of the Information or otherwise as a result of the transaction contemplated hereby, and the Warrant Holder hereby irrevocably waives any claim that it might have based on the failure of the Company to disclose the Information. The Warrant Holder acknowledges that (i) the Company is relying on the Warrant Holder’s representations, warranties, acknowledgments and agreements in this Agreement as a condition to proceeding with the transaction contemplated hereby, and (ii) without such representations, warranties and agreements, the Company would not enter into this Agreement or engage in such transaction.

 

2

 

 

3.              Representations and Warranties. The Company hereby represents and warrants to the Warrant Holder that:

 

3.1               Organization; Power; Authority. The Company is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization and has the full right, power and authority to enter into this Agreement and to repurchase the Warrants from the Warrant Holder and complete the transactions contemplated by this Agreement. This Agreement has been duly authorized, executed and delivered by the Company and constitutes the valid and binding obligation of the Company, enforceable in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium or other similar laws relating to or affecting the rights of creditors generally and by equitable principles.

 

3.2               No Conflicts. The execution, delivery and performance of this Agreement, the repurchase of the Warrants, and compliance with the provisions hereof by the Company, do not and will not, with or without the passage of time or the giving of notice or both, (a) violate any provision of law, statute, ordinance, rule or regulation or any ruling, writ, injunction, order, judgment or decree of any court, administrative agency or other governmental body or authority, or (b) result in any breach of any of the terms, conditions or provisions of, or constitute a default (or give rise to any right of termination, cancellation or acceleration) under, or result in the creation of any lien, security interest, charge or encumbrance upon any of the properties or assets of the Company, under the organizational documents of the Company, or any note, indenture, mortgage or lease, or any other material contract or other instrument, document or agreement, to which the Company is a party or by which it or any of its property is bound or affected. The Company is not a party to, subject to or bound by any agreement or any judgment, order, writ, prohibition, injunction or decree of any court or other governmental body or authority which would prevent the execution or delivery of this Agreement by the Company or the repurchase of the Warrants from the Warrant Holder pursuant to the terms hereof.

 

3.3               Consents. All consents, approvals or authorizations of, or registrations, filings or declarations with, any governmental body or authority or any other person or entity required in connection with the execution, delivery and performance by the Company of this Agreement or the transactions contemplated hereby have been obtained by the Company and are in full force and effect.

 

4.                   Most Favored Nation. The Company hereby represents and warrants as of the date hereof, and covenants and agrees from and after the date hereof through the earlier of (a) the respective expiration dates of the Warrants and (b) the consummation of the Transaction two (2) month anniversary of the Effective Date (such period, the “Covered Period”), that none of the terms offered to, or agreed with, any of the Other Holders with respect to any amendment, settlement, repurchase or redemption (whether pursuant to the terms of such Other Warrants or otherwise) of any of their Other Warrants are or will be more favorable to such Other Holder than those of the Warrant Holder, and this Agreement shall be, without any further action by the Warrant Holder or the Company, deemed amended and modified in an economically and legally equivalent manner such that the Warrant Holder shall receive the benefit of the more favorable terms provided to any such Other Holder. For the avoidance of doubt, the Warrant Holder shall be entitled to receive the highest purchase price per Warrant Share offered to any Other Holder with respect to their Other Warrants during the Covered Period.

 

3

 

 

5.              Release. (a) The Warrant Holder, on behalf of itself and its past, present and future parents, subsidiaries, affiliated entities, predecessors, successors, assigns, agents, representatives and each and every one of their respective past, present and future employees, owners, officers, directors, managers, members, shareholders, representatives, predecessors, successors, assigns, heirs, spouses and executors, jointly and severally (collectively, the “Warrant Holder Releasors”), hereby forever releases and discharges each of the Company and Parent and their respective its past, present and future employees, owners, officers, directors, managers, members, shareholders, representatives, predecessors, successors, assigns, heirs, spouses and executors, jointly and severally (collectively, the “Company Releasees”) from, and unconditionally covenants not to sue, the Company Releasees for any and all claims of any type and all manner of action and actions, cause and causes of action, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, agreements, promises, variances, trespasses, damages, judgments, executions, claims and demands whatsoever, in law or in equity, known or unknown, that any Warrant Holder Releasor may have now or may have in the future, against any of the Company Releases to the extent that those claims arose, may have arisen, or are based on events which occurred at any point in the past up to and including the Effective Date relating to the Warrants or any Warrant Documentation or any and all obligations of any Company Releasee thereunder, but excluding any claims arising out of or pertaining to the enforcement of this Agreement.

 

(b)       The Company, on behalf of itself and its past, present and future parents, subsidiaries, affiliated entities, predecessors, successors, assigns, agents, representatives and each and every one of their respective past, present and future employees, owners, officers, directors, managers, members, shareholders, representatives, predecessors, successors, assigns, heirs, spouses and executors, jointly and severally (collectively, the “Company Releasors”), hereby forever releases and discharges each of the Warrant Holders and its respective past, present and future employees, owners, officers, directors, managers, members, shareholders, representatives, predecessors, successors, assigns, heirs, spouses and executors, jointly and severally (collectively, the “Warrant Holder Releasees”) from, and unconditionally covenants not to sue, the Warrant Holder Releasees for any and all claims of any type and all manner of action and actions, cause and causes of action, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, agreements, promises, variances, trespasses, damages, judgments, executions, claims and demands whatsoever, in law or in equity, known or unknown, that any Company Releasor may have now or may have in the future, against any of the Warrant Holder Releases to the extent that those claims arose, may have arisen, or are based on events which occurred at any point in the past up to and including the Effective Date relating to the Warrants or any Warrant Documentation or any and all obligations of any Warrant Holder Releasee thereunder, but excluding any claims arising out of or pertaining to the enforcement of this Agreement.

 

6.              Miscellaneous.

 

6.1               Assignment. This Agreement and all obligations of the Warrant Holder are personal to the Warrant Holder and may not be transferred or delegated by the Warrant Holder at any time. The Company may freely assign any or all of its rights under this Agreement, in whole or in part, to any successor entity without obtaining the consent or approval of the Warrant Holder.

 

6.2               Other Agreements. Nothing in this Agreement shall limit any of the rights or remedies of the Company or any of the obligations of the Warrant Holder under any other agreement between the Warrant Holder and the Company or any certificate or instrument executed by the Warrant Holder in favor of the Company, and nothing in any other agreement, certificate or instrument shall limit any of the rights or remedies of the Company or any of the obligations of the Warrant Holder under this Agreement.

 

4

 

 

6.3               Governing Law; Jurisdiction; WAIVER OF JURY TRIAL. This Agreement and any dispute or controversy arising out of or relating to this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each Party agrees that all legal proceedings, claims, suits, actions, demands, disputes or controversies (any of the foregoing, a “Proceeding”) concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Proceeding is improper or it is an inconvenient venue for such Proceeding. Each Party agrees that a final judgment in any such Proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable law. Each Party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself or himself, or its or his property, by personal delivery of copies of such process to such party at the applicable address set forth in Section 6.6. Nothing in this Section 6.3 shall affect the right of any Party to serve legal process in any other manner permitted by applicable law. EACH PARTY HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (I) CERTIFIES THAT NO AFFILIATE, AGENT OR REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (II) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6.3.

 

6.4               Counterparts; Electronic Delivery. This Agreement may also be executed and delivered by facsimile signature, by e-mail in portable document format or other electronic delivery in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

6.5               Interpretation. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (a) any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (b) “including” (and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (c) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (d) the term “or” means “and/or”.

5

 

 

6.6               Notices. All notices, requests, and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given, delivered and received (a) upon personal delivery to the party to be notified, (b) when sent by electronic mail upon affirmative confirmation of receipt, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) business day after the business day of deposit with a nationally recognized overnight courier, specifying next-day delivery, with written verification of receipt, in each case to the applicable party at the following addresses (or to such other address for a party as shall be specified by like notice):

 

If to the Company, to:

 

iSpecimen, Inc.
450 Bedford St.
Lexington, MA 02420
Attention: Tracy Curley, CEO
E-mail: tcurley@ispecimen.com 

With a copy (which shall not constitute notice) to:

 

Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas, 11th Floor
New York, New York 10105
Attention: Barry I. Grossman
E-mail: bigrossman@egsllp.com

If to Warrant holder, to  the address of Warrant holder as set forth under the name of Warrant holder on the signature page hereto.

 

6.7               Tax Liability; Fees and Costs. Each Party shall be responsible for its own tax liability resulting from this Agreement. The Parties are responsible for their own fees and costs incurred in connection with the negotiation and execution of this Agreement.

 

6.8               Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of both Parties hereto. No failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

 

6.9               Severability. In case any one or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law.

 

6.10              Specific Performance. The Warrant Holder acknowledges that its obligations under this Agreement are unique, recognizes and affirms that in the event of a breach of this Agreement by the Warrant Holder, money damages may be inadequate and the Company may have not adequate remedy at law, and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed by the Warrant Holder in accordance with their specific terms or were otherwise breached. Accordingly, the Company shall be entitled to seek an injunction or restraining order to prevent breaches of this Agreement by the Warrant Holder and to seek to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition to any other right or remedy to which such party may be entitled under this Agreement, at law or in equity.

 

6.11             Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in or be deemed to have been executed for the benefit of, any person or entity that is not a party hereto or thereto or a successor or permitted assign of such a party.

 

6.12              Entire Agreement. This Agreement constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled and of no further force or effect.

 

{Remainder of page intentionally left blank. Signature pages follow.}

 

6

 

 

IN WITNESS WHEREOF, the Parties have executed this Warrant Repurchase and Termination Agreement as of the date first written above.

 

  Company:
   
  iSpecimen Inc.
 
  By:  
    Name: Tracy Curley
    Title: Chief Executive Officer

 

{Signature page to Warrant Repurchase and Termination Agreement}

 

 

 

 

  Warrant Holder:
   
  By:  
    Name:
    Title:
   
  Address for Notice:

 

{Signature page to Warrant Repurchase and Termination Agreement}

 

 

 

 

EX-101.SCH 3 ispc-20240213.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ispc-20240213_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ispc-20240213_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Feb. 13, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 13, 2024
Entity File Number 001-40501
Entity Registrant Name iSpecimen Inc.
Entity Central Index Key 0001558569
Entity Tax Identification Number 27-0480143
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 450 Bedford Street
Entity Address, City or Town Lexington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02420
City Area Code 781
Local Phone Number 301-6700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol ISPC
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ispecimen.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ispc-20240213.xsd ispc-20240213_lab.xml ispc-20240213_pre.xml tm246435d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm246435d1_8k.htm": { "nsprefix": "ISPC", "nsuri": "http://ispecimen.com/20240213", "dts": { "schema": { "local": [ "ispc-20240213.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ispc-20240213_lab.xml" ] }, "presentationLink": { "local": [ "ispc-20240213_pre.xml" ] }, "inline": { "local": [ "tm246435d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://ispecimen.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-02-13", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm246435d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-02-13", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm246435d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-24-024574-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-024574-xbrl.zip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�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end XML 16 tm246435d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001558569 2024-02-13 2024-02-13 iso4217:USD shares iso4217:USD shares false 0001558569 8-K 2024-02-13 iSpecimen Inc. DE 001-40501 27-0480143 450 Bedford Street Lexington MA 02420 781 301-6700 false false false false Common Stock, par value $0.0001 per share ISPC NASDAQ true false